Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medtronic (MDT)
NYSE:MDT
Medtronic (MDT) Stock Price & Analysis
5,225 Followers
MDT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$67.71 - $89.04
Previous Close$79.19
Volume6.07M
Average Volume (3M)6.38M
Market Cap
$105.15B
Enterprise Value$122.22B
Total Cash (Recent Filing)$8.32B
Total Debt (Recent Filing)$25.18B
Price to Earnings (P/E)25.1
Beta0.63
Next Earnings
May 23, 2024EPS Estimate
$1.45Next Dividend Ex-DateN/A
Dividend Yield3.49%
Share Statistics
EPS (TTM)3.15
Shares Outstanding1,327,822,539
10 Day Avg. Volume6,508,211
30 Day Avg. Volume6,383,554
Standard Deviation0.06
R-Squared0.39
Alpha-0.00543
Financial Highlights & Ratios
Price to Book (P/B)-34.41
Price to Sales (P/S)12.29
Price to Cash Flow (P/CF)10.60
P/FCF Ratio11.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.78
Enterprise Value/Gross Profit5.96
Enterprise Value/Ebitda24.22
Forecast
1Y Price Target
$93.87Price Target Upside18.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
Medtronic News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceF3Q results surpassed expectations with strong organic sales growth leading MDT to raise its sales and EPS projections, signaling management's confidence in the company's future performance.
Product ApprovalFDA approved MDT's next generation TAVR device, Evolut FX Plus, which is expected to enhance the competitiveness of MDT's Evolut platform.
Product PipelineIntroduction of innovative products such as Aurora EV-ICD and PulseSelect, along with positive expectations for the SMART Trial, could strengthen MDT's position in key markets like Cardiovascular.
Bears Say
Clinical Studies And Market ShareThere is no consensus in the clinical community on the importance of BVD and its relevance for eventual structural valve deterioration.
Financial PerformanceForeign exchange and inflation pressures are recognized as challenges to margin expansion, despite positive growth indicators.
Product Portfolio And CompetitionMedtronic's US cryo business saw a decline due to competition from Boston Scientific's PolarX cryo device.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MDT FAQ
What was Medtronic’s price range in the past 12 months?
Medtronic lowest stock price was $67.71 and its highest was $89.04 in the past 12 months.
What is Medtronic’s market cap?
Currently, no data Available
When is Medtronic’s upcoming earnings report date?
Medtronic’s upcoming earnings report date is May 23, 2024 which is in 34 days.
How were Medtronic’s earnings last quarter?
Medtronic released its earnings results on Feb 20, 2024. The company reported $1.3 earnings per share for the quarter, beating the consensus estimate of $1.262 by $0.038.
Is Medtronic overvalued?
According to Wall Street analysts Medtronic’s price is currently Undervalued.
Does Medtronic pay dividends?
Medtronic does not currently pay dividends.
What is Medtronic’s EPS estimate?
Medtronic’s EPS estimate is $1.45.
How many shares outstanding does Medtronic have?
Medtronic has 1,327,822,500 shares outstanding.
What happened to Medtronic’s price movement after its last earnings report?
Medtronic reported an EPS of $1.3 in its last earnings report, beating expectations of $1.262. Following the earnings report the stock price went up 1.684%.
Which hedge fund is a major shareholder of Medtronic?
Among the largest hedge funds holding Medtronic’s share is First Eagle Investment Management LLC. It holds Medtronic’s shares valued at 775M.
---
Medtronic Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$93.87 (18.54% Upside)
$93.87 (18.54% Upside)
Blogger Sentiment
Bullish
MDT Sentiment 92%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 7.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.5%
Last 30 Days ▼ 3.4%
Last 30 Days ▼ 3.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-0.47%
12-Months-Change
Fundamentals
Return on Equity
8.14%
Trailing 12-Months
Asset Growth
-3.50%
Trailing 12-Months
Company Description
Medtronic
Founded in 1949, Medtronic Plc, a medical technology company, develops, manufactures, distributes, and sells device-based medical therapies and services worldwide. It operates through four segments, including Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The company is headquartered in Dublin, Ireland.
---
MDT Company Deck
---
MDT Earnings Call
Q3 2024
0:00 / 0:00
---
MDT Stock 12 Months Forecast
Average Price Target
$93.87
▲(18.54% Upside)
Technical Analysis
Best Analysts Covering MDT
1 Year
1 Year Success Rate
19/22 ratings generated profit
1 Year Average Return
+14.65%
reiterated a buy rating 4 months ago
Copying Kristen Stewart's trades and holding each position for 1 Year would result in 86.36% of your transactions generating a profit, with an average return of +14.65% per trade.
---